Inspira Technologies Oxy BHN L - SIC # 3845 - ELECTROMEDICAL AND ELECTROTHERAPEUTIC APPARATUS

Ticker Exchange SIC # Website Latest Ticker
IINN Nasdaq 3845 https://inspira-technologies.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Inspira Technologies Oxy BHN L

Inspira™ Receives CSA Certification of Compliance to U.S. Standards for the INSPIRA™ ART100 - Apr 25th, 2024 12:00 pm
Inspira™ Signs Term Sheet for Use of INSPIRA™ ART100 Device in Organ Transplant Procedures - Apr 16th, 2024 12:42 pm
Inspira™ and Ennocure In Vitro Study Results Show 100% Prevention of Bacterial Growth that Causes Bloodstream Infections - Apr 10th, 2024 12:24 pm
Inspira™ Announces Program to Pioneer the Applicable Use of the INSPIRA™ ART100 Device for an Artificial Womb - Apr 3rd, 2024 12:30 pm
Inspira™ Announces $1.65 Million Registered Direct Offering of Ordinary Shares by Inspira CEO's Mother with Leading Fund Manager - Apr 1st, 2024 12:00 pm
Companies Like Inspira Technologies Oxy B.H.N (NASDAQ:IINN) Could Be Quite Risky - Mar 27th, 2024 12:52 pm
Inspira™ Technologies Reports Full Year 2023 Financial Results - Mar 25th, 2024 1:20 pm
Inspira Technologies (IINN) Strives to Get AMAR Nod for ART100 - Mar 19th, 2024 5:09 pm
Inspira™ Announces AMAR Regulatory Submission of the INSPIRA™ ART100, to Enter the Southeast Asia and South American Markets - Mar 18th, 2024 11:00 am
Inspira Technologies (IINN) Releases Favorable Data on VORTX - Mar 14th, 2024 2:16 pm
Inspira™ Releases New Data Demonstrating Superiority of its Core Technology, Across Key Endpoints of HMSS Indicator - Mar 12th, 2024 12:00 pm
Inspira™ Announces Plans to Report the Primary Results for a Core Blood Oxygenation Technology Within Days - Mar 4th, 2024 2:20 pm
Inspira™ To Host Conference Call to Discuss Investor Presentation and Announce Next Major Milestone - Feb 27th, 2024 12:02 pm
Inspira™ Announces Breakthrough Update: Nears First FDA 510(k) Approval, 3 U.S. Patents Approved, $546 million in Summary Distribution Agreements - Feb 27th, 2024 12:00 pm
15 Hot Penny Stocks On the Move - Feb 22nd, 2024 5:58 pm
Inspira™ introduces high-end platform for bio-mimicking blood parameters for development and testing of core technologies - Feb 22nd, 2024 12:00 pm
Inspira™ Receives First Ever U.S. Patent Approval for an Orbiting Blood Oxygenation Delivery System - Feb 14th, 2024 12:30 pm
Inspira™ Technologies Collaborates with a Leading Israeli Medical Center for Clinical Evaluation of INSPIRA™ ART Device - Feb 8th, 2024 2:00 pm
Inspira™ Technologies Signs Strategic Agreement to Enter Gulf States with Glo-Med for Deployment of 531 INSPIRA™ ART Devices - Jan 30th, 2024 1:30 pm
Inspira™ Announces Plans to Launch and Target Single-Use Disposable Blood Oxygenation Kit for a New Disposable Perfusion Market Opportunity - Jan 9th, 2024 1:30 pm